Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.80 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.80 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.48 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.41 |
| ▸ | GSR | P00390 | 2/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL17113867 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL27748272 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL26613653 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL1162414 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL17113864 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL9053725 | 0.95 | PTGS1 (0.73) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL9053744 | 0.95 | PTGS1 (0.73) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL16058500 | 0.91 | PTGS1 (0.67) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL418635 | 0.91 | PTGS1 (0.67) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 | |
| Serine SCHEMBL21752129 | 0.91 | PTGS1 (0.67) | PTGS1SLC7A11SLC1A1ENPEPSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116135229-A | Application of hypocrellin-containing derivative with both peri-position and 2-position being simultaneously substituted in preparation of photodynamic anti-tumor drugs | 中国科学院理化技术研究所 | 2023-05-19 | — | — | CN | claimed |
| CN-112638937-A | Pegylated tetanus neurotoxin and hypotonia treatment | 斯诺雷托克斯私人有限公司 | 2021-04-09 | — | — | CN | claimed |
| US-20190030124-A1 | USE OF DERMCIDIN IN STERILE INFLAMMATORY CONDITIONS | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2019-01-31 | — | — | US | claimed |
| CN-107172880-A | Modified antibodies comprising a modified IgG2 domain that elicit agonistic or antagonistic properties and uses thereof | 癌症研究技术有限公司 | 2017-09-15 | — | — | CN | claimed |
| WO-2017070421-A1 | USE OF DERMCIDIN IN STERILE INFLAMMATORY CONDITIONS | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) | 2017-04-27 | — | — | WO | claimed |
| US-20130203129-A1 | POLYPEPTIDES AND BIOSYNTHETIC PATHWAYS FOR THE PRODUCTION OF MONATIN AND ITS PRECURSORS | CARGILL, INCORPORATED (US) | 2013-08-08 | — | — | US | claimed |
| EP-1503985-B1 | POLYPEPTIDES AND BIOSYNTHETIC PATHWAYS | CARGILL INC (US) | 2010-12-15 | — | — | EP | claimed |
| JP-56166285-A | — | — | None | — | — | JP | disclosed |
| WO-2024092274-A2 | ENDOCYTIC AGENTS | BIOVENTURES, LLC (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20220228185-A1 | Recombinant Production of Steviol Glycosides | EVOLVA SA (CH) | 2022-07-21 | — | — | US | disclosed |
| US-11266716-B2 | Use of dermcidin in sterile inflammatory conditions | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2022-03-08 | — | — | US | disclosed |
| US-11254738-B2 | Synthetic antibodies against VEGF and their uses | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO BANTING INSTITUTE (CA) | 2022-02-22 | — | — | US | disclosed |
| US-20210228729-A1 | LGALS3BP ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER | MEDIAPHARMA S.R.L. (IT) | 2021-07-29 | — | — | US | disclosed |
| EP-0900276-A1 | NOVEL CYCLIN-SELECTIVE UBIQUITIN CARRIER POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-03-10 | — | — | EP | disclosed |
| US-5770560-A | TREATING REDUCED HEMOGLOBIN OXYGEN AFFINITY IN MAMMALS | Fischer, James J. (US) | 1998-06-23 | — | — | US | disclosed |
| WO-1997037027-A1 | NOVEL CYCLIN-SELECTIVE UBIQUITIN CARRIER POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1997-10-09 | — | — | WO | disclosed |
| US-4863898-A | Amino acid chelated compositions for delivery to specific biological tissue sites | ALBION INTERNATIONAL, INC. (US) | 1989-09-05 | — | — | US | disclosed |
| JP-S56166285-A | PREPARATION OF ANTIOXIDANT | M S C:KK | 1981-12-21 | — | — | JP | disclosed |
| US-4212945-A | DIPEPTIDE SYNTHESIS FROM AN AMINE-PROTECTED AND FROM A CARBOXY-PROTECTED AMINO ACID, POLAR SOLVENT | (ZAIDANHOJIN) SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1980-07-15 | — | — | US | disclosed |
| US-4212946-A | DIPEPTIDE SYNTHESIS FROM AN AMINE-PROTECTED AND FROM A CARBOXY-PROTECTED AMINO ACID, SOLVENT | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228729-A1 | LGALS3BP ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER | LGALS3BP, LGALS3, LGALS4 | PTGS1 4748/4885SLC7A11 2847/4885SLC1A1 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.